Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer

The expression of the tumor suppressor Merlin is compromised in nervous system malignancies due to genomic aberrations. We demonstrated for the first time, that in breast cancer, Merlin protein expression is lost due to proteasome-mediated elimination. Immunohistochemical analysis of tumor tissues f...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Morrow, K. Adam, Das, Shamik, Meng, Erhong, Menezes, Mitchell E., Bailey, Sarah K., Metge, Brandon J., Buchsbaum, Donald J., Samant, Rajeev S., Shevde, Lalita A.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4951266/
https://ncbi.nlm.nih.gov/pubmed/26908451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7494
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki